Cerebrolysin: a multi-target drug for recovery after stroke.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cerebrolysin: a multi-target drug for recovery after stroke.
- Published In:
- Expert review of neurotherapeutics, 18(8), 681-687 (2018)
- Authors:
- Brainin, Michael
- Database ID:
- RPEP-03595
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03595APA
Brainin, Michael. (2018). Cerebrolysin: a multi-target drug for recovery after stroke.. Expert review of neurotherapeutics, 18(8), 681-687. https://doi.org/10.1080/14737175.2018.1500459
MLA
Brainin, Michael. "Cerebrolysin: a multi-target drug for recovery after stroke.." Expert review of neurotherapeutics, 2018. https://doi.org/10.1080/14737175.2018.1500459
RethinkPeptides
RethinkPeptides Research Database. "Cerebrolysin: a multi-target drug for recovery after stroke." RPEP-03595. Retrieved from https://rethinkpeptides.com/research/brainin-2018-cerebrolysin-a-multitarget-drug
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.